Pages

Wednesday, November 25, 2015

USP Urges FDA To Rethink Biosimilar Naming Guidance Pharmacy Practice News-21 hours ago ... a unique name is necessary,” said Gillian Woollett, MA, DPhil, the senior vice

USP Urges FDA To Rethink Biosimilar Naming Guidance

Pharmacy Practice News-21 hours ago
... a unique name is necessary,” said Gillian Woollett, MA, DPhil, the senior vice 

No comments:

Post a Comment